Treatment of late stage adenocarcinoma
Treatment of late stage adenocarcinoma
Cancer registry in Tanzania and the lung cancer control program
The value of cancer care in low-resource settings
Where have we got to with cancer treatment?
Immunotherapy for NSCLC: Recent advances and future directions
Immunotherapy and targeted agents for elderly lung cancer patients
Challenges in treating elderly lung cancer patients
Checkmate 227: Final analysis for the non small cell lung cancer trial
PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma
Highlights from ESMO 2019
Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC
AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours